Revolution Medicines Inc header image

Revolution Medicines Inc

RVMD

Equity

ISIN null / Valor 52143299

NASDAQ (2026-09-02)

USD 209.23-0.30%

Revolution Medicines Inc
UMushroom community rating:

4.43 3 votes No rating yet

NegativeNeutralPositive

About company

Revolution Medicines is a clinical-stage biopharmaceutical company based in Redwood City, California, focused on discovering and developing small-molecule therapies that target the RAS/MAPK signaling pathway in cancer. The company pursues both direct inhibitors of oncogenic RAS mutants and agents that modulate RAS-dependent signaling nodes (for example, regulatory proteins upstream or downstream of RAS) using structure-guided and chemistry-driven approaches, and it advances multiple programs through preclinical and clinical development aimed at genetically defined tumor populations. Revolution Medicines operates within the precision oncology space, forming collaborations to support development and commercialization activities, and is publicly traded on the Nasdaq.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

429%1Y

497%3Y

602%5Y

Performance

62.6%1Y

59.1%3Y

62.0%5Y

Volatility

44846 M

Market cap (USD)

1,333,392

Daily traded volume (Shares)

43.89 / 42.87

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.43

3 votes

Performance:

5.00

Innovation:

4.57

Society:

4.14

Nature:

3.29

Mathias Charmoy

Switzerland, 01 May 2026

Great

Tilly Chapman

UK, 28 Oct 2025

good performance so far

Atumush Roomabv

Austria, 02 Aug 2023

High performance

EQUITIES OF THE SAME SECTOR

Fagron SA

Fagron SA Valor: 3425437

Annual Return

-50%0%+50%

Risk level

110

-1.35%EUR 22.00

Arvinas Inc

Arvinas Inc Valor: 43526042

Annual Return

-50%0%+50%

Risk level

110

3.34%USD 9.59

Alk-Abello A/S

Alk-Abello A/S Valor: 117689788

Annual Return

-50%0%+50%

Risk level

110

-0.38%DKK 210.00

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252587

Annual Return

-50%0%+50%

Risk level

110

2.46%DKK 44.22

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

0.17%DKK 29.05

L'Oreal S.A.

L'Oreal S.A. Valor: 502805

Annual Return

-50%0%+50%

Risk level

110

1.49%EUR 385.00

Sanofi SA

Sanofi SA Valor: 699381

Annual Return

-50%0%+50%

Risk level

110

0.39%EUR 77.16

EssilorLuxottica SA

EssilorLuxottica SA Valor: 497537

Annual Return

-50%0%+50%

Risk level

110

-0.53%EUR 158.70

Cohance Lifesciences Ltd

Cohance Lifesciences Ltd Valor: 46346459

Annual Return

-50%0%+50%

Risk level

110

-0.17%INR 458.95

Piramal Pharma Limited

Piramal Pharma Limited Valor: 114197705

Annual Return

-50%0%+50%

Risk level

110

0.21%INR 213.65

SIX

FactSet

Clearbit

Logos provided by Clearbit